Abstract
ADVERTISEMENT RETURN TO ISSUEPREVLetterNEXTNucleosides and Nucleotides. 177. 9-(6,7-Dideoxy-β-d-allo-hept-5- ynofuranosyl)adenine: A Selective and Potent Ligand for P3 Purinoceptor-like Protein 1Akira Matsuda, Haruyo Kosaki, Yoshiko Saitoh, Yuichi Yoshimura, Noriaki Minakawa, and Hiroyasu NakataView Author Information Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan, and Department of Molecular and Cellular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo 183-8526, Japan Cite this: J. Med. Chem. 1998, 41, 15, 2676–2678Publication Date (Web):June 30, 1998Publication History Received5 May 1998Published online30 June 1998Published inissue 1 July 1998https://doi.org/10.1021/jm9802822Copyright © 1998 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views131Altmetric-Citations10LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (90 KB) Get e-AlertsSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Ligands,Membranes,Nucleic acids,Receptors,Rodent models Get e-Alerts
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
